Literature DB >> 1361115

The current status of neurotensin-dopamine interactions. Issues and speculations.

A Y Deutch1, D S Zahm.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1361115     DOI： 10.1111/j.1749-6632.1992.tb27353.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  6 in total

1.  Extracerebellar role for Cerebellin1: modulation of dendritic spine density and synapses in striatal medium spiny neurons.

Authors:  S V Kusnoor; J Parris; E C Muly; J I Morgan; A Y Deutch
Journal:  J Comp Neurol       Date:  2010-07-01       Impact factor: 3.215

Review 2.  Receptor-receptor interactions as studied with microdialysis. Focus on NTR/D2 interactions in the basal ganglia.

Authors:  T Antonelli; M C Tomasini; K Fuxe; L F Agnati; S Tanganelli; L Ferraro
Journal:  J Neural Transm (Vienna)       Date:  2006-09-19       Impact factor: 3.575

3.  Neurotensin-deficient mice show altered responses to antipsychotic drugs.

Authors:  P R Dobner; J Fadel; N Deitemeyer; R E Carraway; A Y Deutch
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-26       Impact factor: 11.205

4.  The striatal neurotensin receptor modulates striatal and pallidal glutamate and GABA release: functional evidence for a pallidal glutamate-GABA interaction via the pallidal-subthalamic nucleus loop.

Authors:  L Ferraro; T Antonelli; W T O'Connor; K Fuxe; P Soubrié; S Tanganelli
Journal:  J Neurosci       Date:  1998-09-01       Impact factor: 6.167

5.  Systemic PD149163, a neurotensin receptor 1 agonist, decreases methamphetamine self-administration in DBA/2J mice without causing excessive sedation.

Authors:  Amanda L Sharpe; Erika Varela; Michael J Beckstead
Journal:  PLoS One       Date:  2017-07-07       Impact factor: 3.240

6.  Antagonism of Neurotensin Receptors in the Ventral Tegmental Area Decreases Methamphetamine Self-Administration and Methamphetamine Seeking in Mice.

Authors:  Sergio Dominguez-Lopez; Elisabeth Piccart; William B Lynch; Mackenna B Wollet; Amanda L Sharpe; Michael J Beckstead
Journal:  Int J Neuropsychopharmacol       Date:  2018-04-01       Impact factor: 5.176
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.